Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy.
Maeng HM, Moore BN, Bagheri H, Steinberg SM, Inglefield J, Dunham K, Wei WZ, Morris JC, Terabe M, England LC, Roberson B, Rosing D, Sachdev V, Pack SD, Miettinen MM, Barr FG, Weiner LM, Panch S, Stroncek DF, Wood LV, Berzofsky JA.
Maeng HM, et al. Among authors: wood lv.
Front Oncol. 2021 Dec 16;11:789078. doi: 10.3389/fonc.2021.789078. eCollection 2021.
Front Oncol. 2021.
PMID: 34976830
Free PMC article.